REQUEST A DEMO
Total
USD $0.00
Search more companies

Mitsubishi Tanabe Pharma Malaysia Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Mitsubishi Tanabe Pharma Malaysia Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Mitsubishi Tanabe Pharma Malaysia Sdn. Bhd. is an enterprise based in Malaysia. Its main office is in Kuala Lumpur. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on December 24, 2018. There was a net sales revenue increase of 17.08% reported in Mitsubishi Tanabe Pharma Malaysia Sdn. Bhd.’s latest financial highlights for 2023. Its’ total assets recorded a growth of 10.76%. In 2023, Mitsubishi Tanabe Pharma Malaysia Sdn. Bhd.’s net profit margin decreased by 3.26%.

Headquarters
Suite 8-3, Level 8, Wisma Uoa Damansara Ii,, No.6, Changkat Semantan, Damansara Heights
Kuala Lumpur; Federal Territories; Postal Code: 50490

Contact Details: Purchase the Mitsubishi Tanabe Pharma Malaysia Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Mitsubishi Tanabe Pharma Malaysia Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Mitsubishi Tanabe Pharma Malaysia Sdn. Bhd. report to view the information.
Incorporation Date:
December 24, 2018
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Mitsubishi Tanabe Pharma Malaysia Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
17.08%
Total operating revenue
17.08%
Operating profit (EBIT)
-0.11%
Net Profit (Loss) for the Period
0.39%
Total assets
10.76%
Total equity
10.76%
Operating Profit Margin (ROS)
-4.53%
Net Profit Margin
-3.26%
Return on Equity (ROE)
-2.14%
Quick Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?